Immunotherapy: Powerful combinations

Nature Reviews Cancer 16, 757 (2016). doi:10.1038/nrc.2016.136 Author: Sarah Seton-Rogers Immunotherapies are not effective in all cancer patients, likely due in part to immunosuppressive networks in advanced tumours. Moynihan et al. found that combination immunotherapy consisting of four components (a tumour antigen-targeting antibody, extended half-life recombinant interleukin-2, a programmed cell death protein 1 (PD1)
Source: Nature Reviews Cancer - Category: Cancer & Oncology Authors: Tags: Research Highlight Source Type: research